NorthCrest Asset Manangement’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.34M | Sell |
32,669
-1,863
| -5% | -$248K | 0.12% | 150 |
|
|
2025
Q1 | $4.73M | Buy |
34,532
+2,126
| +7% | +$291K | 0.14% | 143 |
|
|
2024
Q4 | $4.96M | Buy |
32,406
+548
| +2% | +$83.8K | 0.15% | 134 |
|
|
2024
Q3 | $6.18M | Buy |
31,858
+386
| +1% | +$74.8K | 0.19% | 125 |
|
|
2024
Q2 | $7.3M | Buy |
31,472
+38
| +0.1% | +$8.81K | 0.24% | 112 |
|
|
2024
Q1 | $6.78M | Buy |
31,434
+365
| +1% | +$78.7K | 0.23% | 118 |
|
|
2023
Q4 | $8.04M | Sell |
31,069
-930
| -3% | -$241K | 0.3% | 100 |
|
|
2023
Q3 | $8.22M | Buy |
31,999
+608
| +2% | +$156K | 0.34% | 94 |
|
|
2023
Q2 | $8.94M | Sell |
31,391
-155
| -0.5% | -$44.2K | 0.35% | 92 |
|
|
2023
Q1 | $8.77M | Sell |
31,546
-77
| -0.2% | -$21.4K | 0.37% | 92 |
|
|
2022
Q4 | $8.76M | Sell |
31,623
-928
| -3% | -$257K | 0.5% | 71 |
|
|
2022
Q3 | $8.69M | Sell |
32,551
-117
| -0.4% | -$31.2K | 0.47% | 80 |
|
|
2022
Q2 | $6.66M | Buy |
32,668
+499
| +2% | +$102K | 0.34% | 103 |
|
|
2022
Q1 | $6.78M | Buy |
32,169
+6,196
| +24% | +$1.3M | 0.32% | 107 |
|
|
2021
Q4 | $6.23M | Buy |
+25,973
| New | +$6.23M | 0.34% | 93 |
|